Form 8-K - Current report:
SEC Accession No. 0001140361-22-027565
Filing Date
2022-08-01
Accepted
2022-08-01 08:32:00
Documents
14
Period of Report
2022-07-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K edge20002003x10_8k.htm   iXBRL 8-K 26556
2 EXHIBIT 99.1 edge20002003x10_ex99-1.htm EX-99.1 78101
3 EXHIBIT 99.2 edge20002003x10_ex99-2.htm EX-99.2 13627
  Complete submission text file 0001140361-22-027565.txt   276704

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cbio-20220731.xsd EX-101.SCH 3907
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20220731_lab.xml EX-101.LAB 22546
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20220731_pre.xml EX-101.PRE 16072
8 EXTRACTED XBRL INSTANCE DOCUMENT edge20002003x10_8k_htm.xml XML 4058
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 221122914
SIC: 2834 Pharmaceutical Preparations